16 Apr
2015
16:30 E.S.T.

Cellectis Plant Sciences, Inc. Locks Early CRISPR Intellectual Property Uses in Plants

Read more

15 Apr
2015
16:30 E.S.T.

Cellectis Plant Sciences, Inc. Publishes a Study Demonstrating Reduced Acrylamide in Fried Potatoes

Read more

09 Apr
2015
16:30 E.S.T.

Cellectis Opens Labs and Offices in Manhattan, New York

Read more

25 Mar
2015
16:30 E.S.T.

Cellectis Prices Initial Public Offering of American Depositary Shares

Read more

04 Mar
2015
16:30 E.S.T.

Cellectis: 2014 financial results

Read more

17 Feb
2015
16:30 E.S.T.

Cellectis SA Shareholders General Meeting of February 16, 2015

Read more

13 Jan
2015
16:30 E.S.T.

Cellectis and The Ohio State University, Through the Ohio State Innovation Foundation, Enter Into Licensing Agreement for Chimeric Antigen Receptor Technology Targeting Multiple Myeloma

Read more

08 Jan
2015
16:30 E.S.T.

Cellectis Plans to Conduct Registered Initial Public Offering in the U.S.

Read more

06 Jan
2015
16:30 E.S.T.

Cellectis announces the issuance by the USPTO of a patent covering a seminal nuclease-based “gene editing” method

Read more